NTLA (NTLA)

$13.13
-4.37%
$2.0B
Market Cap
P/E Ratio
1.93
Beta
Dividend Yield
Piotroski 3/9Altman Z 0.3 DistressROIC−WACC -63.6%

Quantitative Summary

Deterministic

Below-average fundamentals indicated by Piotroski score of 3/9; Altman Z of 0.3 falls in the academic distress zone.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics of NTLA reveal a severe disconnect between capital efficiency and revenue expansion, characterized by an ROIC-WACC spread of -63.6%, indicating that the company is currently destroying value at a rate far exceeding its cost of equity. This negative valuation driver stems from abysmal profitability metrics; with net margins collapsing to -609.8% and a Profitability Factor (RMW) score of -2.372, the business model has not yet achieved sustainable earnings generation despite posting 16.9% year-over-year revenue growth. The DuPont decomposition is obscured by these losses, but the low Piotroski F-Score of 3/9 and an Altman Z-Score of merely 0.3 signal significant financial distress and a heightened probability of bankruptcy relative to industry peers. These qualitative red flags suggest that current top-line momentum is insufficient to offset the structural weaknesses in capital allocation and operational leverage.

From a valuation perspective, the market appears to be pricing in substantial uncertainty rather than immediate cash flow stability. While specific historical P/E comparisons are unavailable due to negative earnings, the implied growth assumptions required for any positive DCF fair value would need to dramatically outpace the current 16.9% revenue trajectory to overcome the massive drag on returns caused by the -47.2% ROIC. The stock's exposure to a Growth tilt (Value Factor of -0.767) suggests it is being evaluated primarily on future potential rather than intrinsic asset value, leaving little margin for error if execution lags. Consequently, the current pricing reflects a high-risk premium where any deviation from aggressive growth targets could trigger a rapid repricing based on the underlying lack of profitability and poor balance sheet health indicated by the Altman metric.

Risk factors further complicate the risk-reward profile, as evidenced by a Fama-French Alpha of 1.16%, which indicates that past performance has slightly outpaced what would be expected given its size and value characteristics, potentially masking underlying structural issues with short-term momentum. However, this alpha does not compensate for the fundamental deterioration highlighted by the weak profitability factor or the negative spread between returns on invested capital and the weighted average cost of capital. The convergence of a distressed Altman Z-Score and minimal Piotroski score creates an asymmetric risk environment where downside protection is limited, while upside remains contingent upon a successful transition to positive margins that has not yet materialized in the financial statements.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

3/9
Piotroski F-Score
Weak — below-average operational and profitability metrics
0.3
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.

Profitability & Value Creation

-609.8%
Net Margin
-47.2%
ROIC
16.4%
WACC
ROIC − WACC Spread: -63.6%— Negative spread.
+16.9%
Revenue Growth (YoY)
+20.5%
Earnings Growth (YoY)
-395.9M
Free Cash Flow

Balance Sheet Health

0.25x
Debt / Equity
5.08x
Current Ratio
-26.30%
FCF Yield
-425.1M
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $-1.27
Act: $-1.10
+13.5%
Q3
✓ Beat
Est: $-1.01
Act: $-0.98
+2.5%
Q2
✓ Beat
Est: $-1.00
Act: $-0.92
+7.8%
Q1
✓ Beat
Est: $-0.96
Act: $-0.83
+13.7%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Risk Profile

80.6%
Annual Volatility
1.19
Sharpe (1Y)
-0.05
Sharpe (3Y)
-86.4%
Max Drawdown (3Y)
-96.5%
Max Drawdown (5Y)

Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fama-French 5-Factor Exposure

Academic factor model decomposition — what's really driving this stock's returns.

0.83
Market β
Mkt-RF
+2.301
Size (SMB)
Small-cap tilt
-0.767
Value (HML)
Growth tilt
-2.372
Profit (RMW)
Weak
+0.775
Invest (CMA)
Conservative
Alpha (annual): +1.16%
R²: 36.1%of variance explained by 5 factors

Fama-French 5-Factor Model. Data: Kenneth French Data Library. Regression over 3 years of daily returns.

Fundamentals

-7.7
Forward P/E
PEG Ratio
2.73
Price/Book
6M
Avg Volume
$28.25
52W High
$6.92
52W Low
29%
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$260M
Tracked Passive Exposure
5
ETFs Holding NTLA
0.35%
Avg Weight in ETFs
$74B
Total ETF AUM

When investors buy or sell ETFs like ARKG or ARKK, the fund manager is mechanically forced to buy or sell NTLA shares regardless of NTLA's individual fundamentals. We estimate $260M of passive capital is structurally linked to NTLA through 5 tracked ETFs. Passive flows have a limited but growing influence on NTLA's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 5 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in NTLA to visualize passive redemption contagion across ETFs and collateral stocks.

NTLA Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
NTLAEpicenterVBKETFVHTETFXBIETFCRSPLow RiskTEMHigh RiskTWSTLow RiskLLYLow RiskTSLALow Risk
NTLA Price Drop (%)0

If NTLA (NTLA) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies CRISPR THERAPEUTICS AG (CRSP) as the most exposed collateral stock, sharing 3 ETFs with NTLA. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 5 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

NTLA Ownership Dynamics

Passive funds hold 1 in every 6 NTLA shares, reducing daily market volatility.

Ticker
NTLA
Total Shares
140M
ETF Lock-Up
15.5%
Display Mode
Total Float Impact
15.5%Locked Float

NTLA (NTLA) exerts notable gravity on the passive index market, currently representing 3.4% of the ARK Genomic Revolution ETF (ARKG) and 2.3% of the ARK Innovation ETF (ARKK). Across 5 tracked ETFs, approximately 22M shares (15.5% of float) are held by passive funds and rarely trade on the open market. This level of passive ownership means index rebalances can create outsized volume events.

Float lock-up computed from 5 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

NTLA Institutional Volume Profile

252-day volume distribution by price level. The Point of Control (POC) marks the price where the most institutional volume transacted — an implicit support/resistance floor.

TICKER
NTLA
PRICE
$13.13
FLOOR (POC)
$13.85
STRENGTH
High
$7$98%$1011%$117%$1215%$1318%$13.13$14POC 18%$157%$16$17$18$19$20$21$22$23$25$26$27$28
Focus Zone
Point of Control (POC) Support (below price) Resistance (above price) Current Price

The highest-volume price zone for NTLA over the past year sits near $13.85 (18% of 252-day volume). The current price of $13.13 sits 5.2% below the POC — suggesting potential mean-reversion upside if institutional demand reasserts at this level. The highly concentrated volume profile (18% at POC) indicates strong consensus on fair value — institutional participants have repeatedly transacted near this price.

Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-1418,575$14.28$265,251
2026-05-12184$14.42$2,653.28
2026-05-061,208$13.31$16,078.48
2026-05-0558,300$13.87$808,621
2026-05-041,247$13.26$16,535.22
2026-05-011,246$13.48$16,796.08
2026-04-30190,818$12.45$2.4M
2026-04-28602,801$13.04$7.9M
2026-04-2427,013$15.87$428,696.31
2026-04-2260,755$15.31$930,159.05
2026-04-21531$15.21$8,076.51
2026-04-202,900$14.95$43,355
2026-04-1720,212$14.16$286,201.92
2026-04-165,259$14.94$78,569.46
2026-04-156,995$14.78$103,386.1
2026-04-1412,468$14.26$177,793.68
2026-04-138,037$13.49$108,419.13
2026-04-106,651$13.83$91,983.33
2026-04-071,388$13.30$18,460.4
2026-04-06229$13.13$3,006.77
2026-04-011,186$12.82$15,204.52
2026-03-27599$13.24$7,930.76
2026-03-242,475$13.11$32,447.25
2026-03-10277,080$13.89$3.8M
2026-03-0515,086$13.82$208,488.52
2026-03-031,489,328$15.44$23.0M
2026-02-2763,721$14.28$909,935.88
2026-02-2614,110$13.42$189,356.2
2026-02-2519,608$13.58$266,276.64
2026-02-2412,586$13.16$165,631.76

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Price Correlations

Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.

Peer252-Day (1Y)126-Day (6M)Direction
WTGXXNaNNaN
BEAM0.6150.584Moderate
CRSP0.6030.595Moderate
PRME0.4800.572Moderate
RXRX0.4710.415Moderate
SDGR0.4040.437Moderate
ABSI0.4030.399Moderate
BFLY0.3950.372Moderate
PACB0.3750.337Moderate
VCYT0.3660.427Moderate

Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.

Compare NTLA to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.